Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1982 1
1984 2
1985 1
1986 1
1987 1
1988 1
1989 1
1990 1
1991 1
1992 2
1993 5
1994 3
1995 3
1997 5
1998 3
1999 9
2000 17
2001 13
2002 11
2003 20
2004 26
2005 24
2006 34
2007 32
2008 30
2009 35
2010 66
2011 63
2012 69
2013 69
2014 61
2015 83
2016 89
2017 94
2018 108
2019 111
2020 181
2021 239
2022 23
Text availability
Article attribute
Article type
Publication date

Search Results

1,361 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Mortagi
Page 1
Premenstrual disorders.
Yonkers KA, Simoni MK. Yonkers KA, et al. Am J Obstet Gynecol. 2018 Jan;218(1):68-74. doi: 10.1016/j.ajog.2017.05.045. Epub 2017 May 29. Am J Obstet Gynecol. 2018. PMID: 28571724 Review.
Choice of contraceptives.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2018 Oct 8;60(1557):161-168. Med Lett Drugs Ther. 2018. PMID: 30335731 No abstract available.
Author Spotlight: Yasmin G. Hernandez-Barco.
Hernandez-Barco YG. Hernandez-Barco YG. Dig Dis Sci. 2020 Aug;65(8):2170. doi: 10.1007/s10620-020-06447-4. Dig Dis Sci. 2020. PMID: 32661761 No abstract available.
Hormonal contraception in women with endometriosis: a systematic review.
Grandi G, Barra F, Ferrero S, Sileo FG, Bertucci E, Napolitano A, Facchinetti F. Grandi G, et al. Eur J Contracept Reprod Health Care. 2019 Feb;24(1):61-70. doi: 10.1080/13625187.2018.1550576. Epub 2019 Jan 21. Eur J Contracept Reprod Health Care. 2019. PMID: 30664383
Only two COC preparations (ethinylestradiol [EE]/norethisterone acetate [NETA] and a flexible EE/drospirenone regimen) demonstrated significantly increased efficacy compared with placebo. ...
Only two COC preparations (ethinylestradiol [EE]/norethisterone acetate [NETA] and a flexible EE/drospirenone regimen) demonstrated s …
Yasmin: the reason why.
Thorneycroft IH. Thorneycroft IH. Eur J Contracept Reprod Health Care. 2002 Dec;7 Suppl 3:13-8; discussion 42-3. Eur J Contracept Reprod Health Care. 2002. PMID: 12659402 Review.
Most non-contraceptive benefits are due to the progestogen component and its inhibition of ovulation. The new drospirenone-containing oral contraceptive (Yasmin, Schering AG, Berlin, Germany) offers the traditional non-contraceptive benefits; however, due to its uni …
Most non-contraceptive benefits are due to the progestogen component and its inhibition of ovulation. The new drospirenone-containing …
The comparison of the effectiveness and safety of drospirone ethinyl estradiol and ethinyl estradiol cyproterone in the treatment of polycystic ovarian syndrome: A protocol for systematic review and meta-analysis.
Liu Z, Song Y, Xu Y, Wang J, Hu H, Weng Y. Liu Z, et al. Medicine (Baltimore). 2020 Dec 18;99(51):e23811. doi: 10.1097/MD.0000000000023811. Medicine (Baltimore). 2020. PMID: 33371158 Free PMC article. Clinical Trial.
At present, for the treatment of PCOS patients, clinical treatment mainly includes hypoglycemia, insulin and menstrual regulation and other symptomatic and supportive treatment. Drospirone ethinyl estradiol and ethinyl estradiol cyproterone are 2 of th …
At present, for the treatment of PCOS patients, clinical treatment mainly includes hypoglycemia, insulin and menstrual regulation and other …
Diarrhoea and the COVID-19 pandemic.
Gaber Y. Gaber Y. Arab J Gastroenterol. 2020 Sep;21(3):146-150. doi: 10.1016/j.ajg.2020.06.001. Epub 2020 Jul 14. Arab J Gastroenterol. 2020. PMID: 32680695 Free PMC article. Review.
A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome.
Li J, Ren J, Sun W. Li J, et al. Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:13-21. doi: 10.1016/j.ejogrb.2016.11.013. Epub 2016 Nov 16. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 27923166 Review.
OBJECTIVES: To systematically review the impact of Yasmin (drospirenone pill) compares with other standard treatments for symptoms of Polycystic Ovary Syndrome (PCOS). STUDY DESIGN: The relevant studies of the randomized controlled trials in women with PCOS treated …
OBJECTIVES: To systematically review the impact of Yasmin (drospirenone pill) compares with other standard treatments for symp …
Yasmin advert withdrawn--why and how.
[No authors listed] [No authors listed] Drug Ther Bull. 2003 Mar;41(3):17-8. Drug Ther Bull. 2003. PMID: 12683099
In April 2002, Schering Health Care launched its combined oral contraceptive (COC) pill Yasmin in the UK with an advertising campaign that centred on claimed 'lifestyle' advantages of the product. In our August 2002 article 'Is Yasmin a "truly different" pill?', we …
In April 2002, Schering Health Care launched its combined oral contraceptive (COC) pill Yasmin in the UK with an advertising campaign …
1,361 results